Genomic and transcriptomic changes in B-cell malignancies following BTK inhibitor treatment

Identifying resistance mechanisms and oncogenic shifts post-BTK inhibitor therapy

INDICATION

Blood

BIOMARKER

BTK

Horizontal bar chart of top altered gene frequencies, comparing pre- and post-treatment groups.
Frequency of patients with alterations in each gene and comparing between pre- and post-treated samples with BTKi. Only including top altered genes.

Related cases

Lens Library

Abstract grid of squares showing color gradients and clustered data points.

Shorter Pluvicto treatment course for patients with prostate cancer and high initial PSA

PSA

Prostate

Lens Library

Visualization showing multiple rows of blue and orange squares, divided by a black dotted line.

Genomic and transcriptomic differences between early-onset and non-early-onset PDAC

Evaluating MTAP deletion and immune profile scores to identify unmet needs in solid tumors